MedTrace Logo

Electroretinogram in Autistic Spectrum Disorders

NCT03422016 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 177

Last updated 2022-01-11

No results posted yet for this study

Summary

This study aims to find out the incidence of a reduced light adapted electroretinogram (ERG) b-wave amplitude in children with a diagnosis of Autism Spectrum Disorders (ASD).

Conditions

Interventions

DIAGNOSTIC_TEST

electroretinogram (ERG)

an ERG is a measure of the eyes response to a flash of light

Sponsors & Collaborators

  • Flinders University

    collaborator OTHER

  • Yale University

    collaborator OTHER

  • Swinburne University of Technology

    collaborator OTHER

  • Great Ormond Street Hospital for Children NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Dorothy A Thompson, PhD · Consultant Clinical Scientist Visual Electrophysiology, Great Ormond Street Hospital for Children London UK

  • Paul Constable, PhD · Head Of Teaching Optometry, Flinders Vision Autism Centre, Flinders University, Australia

  • James McPartland, PhD · Associate Professor of Child Psychiatry and Psychology, Director, Yale Developmental Disabilities Clinic, Yale University, USA

Eligibility

Min Age
4 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-03
Primary Completion
2020-03-03
Completion
2020-04-03

Countries

  • United States
  • Australia
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03422016 on ClinicalTrials.gov